SOPH
SOPHiA GENETICS S.A.
NASDAQ · CHHealthcareMedical - Healthcare Information Services
$6.33+7.84%
Price as of Jul 20, 2026
SOPH valuation
SOPHiA GENETICS S.A. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.71x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 9.95x
- Price / sales
- 5.60x
- Price / cash flow
- -10.79x
Enterprise value
- Enterprise value
- $451.5M
- EV / sales
- 5.56x
- EV / EBITDA
- -6.83x
- EV / EBIT
- -6.29x
- Market cap
- $454.4M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.